This week$Hang Seng Index (800000.HK)$It closed at 18675 points, up 1102 points, or about 6.3%, during the week.$Hang Seng TECH Index (800700.HK)$It closed at 3878.81 points, up 10.8% during the week.

In terms of Hong Kong stock IPO, a total of this week3Only new share delivery form3Only new shares have been informed.7Only new offerings and2Only new shares are listed.

Among them, it is worth noting that the largest domestic participant in China's ophthalmic medical device market$GAUSH MEDITECH (02407.HK)$, Internet of things application provider$HOWKINGTECH (02440.HK)$In the middle ofIn the hot IPOThe latter has been 47 times oversubscribed (as of December 3)；

Last week, there was a Chinese credit technology platform.$360 DIGITECH-S (03660.HK)$be listed,As of December 3, the closing price has increased by more than 22.7% over the issue price, and the overall performance is better.

This week.3Only new share delivery table, where:

Pharmacist gangIt is a B2B pharmaceutical e-commerce enterprise, with 333000 related drugstores, accounting for more than half of the total number of drugstores in the country. As the domestic head of B2B pharmaceutical e-commerce, the revenue growth rate is significantly ahead of the traditional pharmaceutical wholesale enterprises.

According to Frost Sullivan, the pharmacist gang has become the largest digital service platform for China's out-of-hospital pharmaceutical industry in terms of the total volume of commodity transactions in 2021.

Zhongtian constructionIt is a well-known general contracting construction group in Hunan Province with an operating history of more than 40 years. The company has 5 first-class construction qualifications. According to Frost Sullivan's report, in terms of construction revenue in 2021, the company is the fifth largest non-state-owned construction enterprise in Hunan province with first-class contracting qualifications, with a market share of about 0.2%. At the same time, the market share of China's construction industry in Hunan Province is about 4.5%.

The company is mainly committed to providing engineering construction services, including civil construction services, municipal engineering services, foundation engineering services and other professional contracted projects, including professional contracting of building decoration and decoration projects.

Boan biologyFounded in 2013 and acquired by Green Leaf Pharmaceutical Group in 2020, it is engaged in the development of therapeutic antibodies, focusing on common major therapeutic areas, including oncology, metabolism, autoimmunity and ophthalmology.

All of the company's revenue comes from the sales of Boyonol, a bioanalogue product. At present, the company has not made a profit, recording a loss for two and a half years in a row, and has lost about 619 million yuan from 2020 to the first half of 2022.

This week3Only new shares have heard the news.

Tiantu investmentFounded in 2002, it is a venture capital institution focusing on the consumer sector. As of June 30, 2022, the total asset management scale of Tiantu investment is about 24.7 billion yuan, of which the fund is about 19.6 billion yuan, and its managed fund has achieved an average internal rate of return of 20.5%.

From 2019 to 2021, Tiantu ranked third among all private equity investors in the number of investment projects invested in China's consumer industry, after Tencent Investment and Sequoia Capital China, according to Zhaoshi Consulting.

Think of school healthFounded in 2014, its business consists of three parts, specialty pharmacy business, doctor research assistance and health insurance services. Based on revenue in 2021, the company's specialty pharmacy business operates the largest private specialty pharmacy in China, with an income of about 2.9 billion yuan and a market share of 7 per cent, according to Zhenshi Consulting.

As of October 25, 2022, Tencent has become its largest shareholder through its wholly-owned subsidiary TencentMobility and its controlled TPPFollow-on, which jointly owns 27.77% of the shares.

TechStar Acquisition CorporationIs a special purpose acquisition company (SPAC) that intends to focus on identifying high-growth special purpose mergers and acquisitions targets in the "new economy" area. The sponsors of the company are Xinyin Capital, Qingke Group, Qingke Capital, Mr. Ni Zhengdong, Mr. Li Zhu and Mr. Liu Weijie. Qingke Group and Qingke Capital are finally controlled by Mr. Ni.

There are seven new offerings this week.

$GAUSH MEDITECH (02407.HK)$It is proposed to issue about 13.07 million shares, including 1.307 million shares for public offering and 11.76 million shares for international offering at an issue price of HK $51.40 per share, which is expected to be listed on December 12.

According to Frost Sullivan, Gaoshi Medical is the largest domestic and fourth largest player in China's ophthalmic medical device market (dominated by overseas competitors and highly competitive) in terms of income in 2021, with a market share of 6.7%. With a track record of more than 20 years, the company distributes a wide range of ophthalmic medical equipment and consumables and provides related technical services to end customers.

Related readings:"A picture is understood | Gaoshi Medical is listed in Hong Kong and is the largest domestic participant in China's ophthalmic medical device market."

$Huafang Group (03611.HK)$The issue price per share is HK $2.80-3.60 per share, with 1000 shares per share, which has been 10.43 times oversubscribed as of press time.

The company is the "veteran" of the live broadcasting industry, providing users with audio and video live entertainment and social network services. According to the iResearch consultancy report, Huafang Group ranks third among all online entertainment live streaming platforms in China in terms of revenue from mobile and PC applications and websites as well as WeChat Mini Programs in 2021. It accounts for about 13.1% of the total revenue of China's entertainment live platform in 2021 and about 0.9% of the total revenue of China's audio and video social entertainment market.

$HOWKINGTECH (02440.HK)$It is in the midst of a hot IPO; as of press time, the margin multiple has exceeded 47 times. The company plans to issue 36 million shares, of which 3.6 million shares will be offered to the public and 32.4 million shares will be offered internationally at a price of HK $2.73 to HK $3.28 per share. The offering will close on December 5.

$Buyang International (02457.HK)$It plans to sell 250 million shares of 5000 shares each, raising a maximum of HK $150 million.

Buyang International is an aluminum alloy steam turbine manufacturer, focusing on the aftermarket, that is, the spare parts market for automobile repair and maintenance. The company manufactures and sells all kinds of aluminum alloy steam turbines to customers. According to Frost Sullivan, according to the export price of aluminum alloy steam turbine, the company accounts for about 1.0% of China's aluminum alloy steam turbine market in 2021.

Two new shares have been listed this week, including:

$LYGEND RESOURCE (02245.HK)$The first day opened flat at HK $15.80, with a pre-market turnover of HK $101 million.

$360 DIGITECH-S (03660.HK)$It rose 3.44% on its first day of trading and closed up 22.7% from its offering price as of December 3. In the dark trading of Fortune, 360 DigiTech Inc-S closed up 1.14% at HK $50.60, earning HK $28.50 per transaction.

360 DigiTech Inc is a Chinese credit technology platform founded in 2016, providing a full range of technology services, including assisting financial institutions, consumers and small and micro enterprises in the loan life cycle. the scope of services include access to borrowers, preliminary credit assessment, capital matching and post-loan services, with the IOU application as the main user interface.